Back
Xenon Pharmaceuticals Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Buy
61
XENE
Xenon Pharmaceuticals
Last Price:
41.21
Seasonality Move:
29.08%
Buy
79
AUPH
Aurinia Pharmaceuticals
Last Price:
8.88
Seasonality Move:
24.51%
Buy
61
Xenon Pharmaceuticals (XENE)
is a Buy
Is Xenon Pharmaceuticals a Buy, Sell or Hold?
- The current Xenon Pharmaceuticals [XENE] share price is $41.15. The Score for XENE is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- XENE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
79
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $8.86. The Score for AUPH is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- AUPH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XENE Stock Price Chart
What is Xenon Pharmaceuticals's stock price today?
-
The Xenon Pharmaceuticals share price today is $41.15
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XENE is experiencing buying pressure, which is a positive indicator for future bullish movement.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $8.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing slight buying pressure.
XENE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.49 | Sell |
| Relative Strength Index (14 RSI): | 48.82 | Sell |
| Chaikin Money Flow: | 174138 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.11 - 43.85) | Sell |
| Bollinger Bands (100): | (39.06 - 42.88) | Buy |
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 72.92 | Buy |
| Chaikin Money Flow: | 122744 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.17 - 8.37) | Buy |
| Bollinger Bands (100): | (5.81 - 7.63) | Buy |
XENE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.12 | Buy |
| 20-day SMA: | 41.87 | Sell |
| 50-day SMA: | 41.22 | Sell |
| 200-day SMA: | 41.49 | Sell |
| 8-day EMA: | 40.52 | Buy |
| 20-day EMA: | 41.31 | Sell |
| 50-day EMA: | 41.29 | Sell |
| 200-day EMA: | 40.74 | Buy |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.34 | Buy |
| 20-day SMA: | 7.95 | Buy |
| 50-day SMA: | 7.43 | Buy |
| 200-day SMA: | 6.09 | Buy |
| 8-day EMA: | 8.41 | Buy |
| 20-day EMA: | 8.03 | Buy |
| 50-day EMA: | 7.49 | Buy |
| 200-day EMA: | 6.84 | Buy |
Xenon Pharmaceuticals Earnings Growth & XENE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.42 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.54 per share.
Xenon Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aurinia Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||